UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
EU starts evaluating Samsung Bioepis’ sales application for Avastin biosimilar
Samsung Bioepis said that the European Medicines Agency (EMA) has started e...
by Lee Han-soo
|
2019-07-19 17:01
라인
MedPacto passes tech assessment, seeks KOSDAQ listing this year
MedPacto, a subsidiary of Theragen Etex, is pushing be listed on the KOSDAQ...
by Jeong Sae-im
|
2019-07-19 17:01
라인
Employees file suit against Galderma Korea
Galderma Korea has recently been sued by its labor union. The company’s lab...
by Kim Yun-mi
|
2019-07-19 15:41
라인
Vaccines foreigners should get before visiting Korea for vacation
Korea has become a popular summer vacation destination for foreigners over ...
by Lee Han-soo
|
2019-07-19 14:53
라인
Celltrion targets Chinese biosimilar market through joint venture
Celltrion said it has established Vcell Healthcare Ltd., a joint venture wi...
by Lee Han-soo
|
2019-07-19 14:53
라인
Migrant worker group lashes mandatory health insurance subscription for foreigners
Foreigners who stay longer than six months in Korea will have to subscribe ...
by Lee Han-soo
|
2019-07-18 17:46
라인
Government employee stages one-person protest against own ministry
Kang Yoon-hee has been working as a committee member of the Clinical Trial ...
by Lee Hye-seon
|
2019-07-18 17:07
라인
‘Insurance benefits needed for Ibrance-fulvestrant combo treatment’
In Korea where the age of breast cancer patients is low, there is an urgent...
by Kim Yun-mi
|
2019-07-18 17:04
라인
2 cancer immunotherapy makers face different situations in reimbursement talks
Bristol-Meyers Squibb (BMS) is reportedly having a hard time persuading its...
by Kim Yun-mi
|
2019-07-18 16:01
라인
Bridge Biotherapeutics licenses out IPF treatment candidate to Boehringer
Bridge Biotherapeutics said that it has licensed out BBT-877, an idiopathic...
by Lee Han-soo
|
2019-07-18 15:58
라인
GC Labcell releases pre-clinical trial results for NK cell treatment
GC Labcell said that it has published the pre-clinical trial results for MG...
by Lee Han-soo
|
2019-07-18 14:22
라인
Sanofi vaccinates Gwangju FINA Championships staffs against hepatitis A
Sanofi Pasteur Korea said that it has vaccinated 300 staffs working for the...
by Lee Han-soo
|
2019-07-18 10:49
라인
Genomictree targets multimillion-dollar US market with non-invasive diagnostic kit
Genomictree is on the threshold of advancing to the U.S. market for non-inv...
by Park Gi-taek
|
2019-07-18 09:00
라인
CrystalGenomics’ US partner starts injecting leukemia treatment candidate
CrystalGenomics said Tuesday that its U.S. partner, Aptose Bioscience has i...
by Lee Han-soo
|
2019-07-17 17:45
라인
‘RIGHT Fund aims to use Korean innovation for global health equity’
Infectious diseases remain a leading cause of deaths worldwide and have bee...
by Lee Han-soo
|
2019-07-17 17:41
라인
Biopharmaceutical stocks face grim outlook in 2H
Biopharmaceutical stocks remain sluggish in the second half. Stock prices h...
by Jeong Sae-im
|
2019-07-17 14:11
라인
Korean, Japanese healthcare firms reaffirm ‘joint growth’ amid trade feud
Medicine and medical equipment makers from Korea and Japan gathered to disc...
by Jeong Sae-im
|
2019-07-17 14:06
라인
RIGHT Fund reveals 1st investment into public health projects in developing countries
The Research Investment for Global Health Technology Fund, or RIGHT Fund, p...
by Lee Han-soo
|
2019-07-17 14:03
라인
[Special] Konyang University Hospital aims to soar on crest of Watson
The Watson fever has been waning among domestic medical institutions. Some ...
by Song Soo-youn
|
2019-07-17 11:39
라인
'Biktarvy -- a pill a day to treat HIV'
Gilead Science Korea plans to lower the likelihood of treatment failure and...
by Lee Han-soo
|
2019-07-17 10:09
-
이전
111
112
113
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top